Germany Computed Tomography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany Computed Tomography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany computed tomography market was valued at USD 422.83 million in 2021 and is projected to register a CAGR of 6.25% during the forecast period (2022-2027).

The COVID pandemic had an adverse effect on market growth. Germany stopped all elective studies and treatments aimed at patients with advanced tumors as a result of COVID-19. According to Ken Herrmann, Chair, Department of Nuclear Medicine, Universitatsklinikum Essen, Essen, Germany, thyroid outpatients decreased by 95%, and CT decreased by 60% in the article "Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences" published in April 2020. Due to this, they were only able to put one-third of their workforce on site. Aside from its negative effects, COVID-19 has given players in this industry the chance to build their presence by releasing new treatments or advancing clinical research in this area. For instance, In addition, several diagnostic tests for the thyroid (15.9%), bone (8.8%), lung (7.6%), sentinel lymph nodes (5.5%), and myocardium (1.4%) were decreased in comparison to 2019 procedures, according to an article titled "Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey" that was published in June 2021. Thus, the market is expected to increase in the future.

The high incidence rate of chronic diseases, such as diabetes, is a primary driver of the computed tomography market in Germany. The country's market is additionally influenced by the nation's ageing population growth, technological developments in the relevant industry, expanding R&D practises, rising investments, and a rise in product releases. Germany is one of the 57 nations in the International Diabetes Federation (IDF) European zone, with a prevalence rate of adults with diabetes of 15.3 percent and 9,510,500 cases overall, according to the International Diabetes Federation. The nation's high prevalence of diabetes will contribute to the anticipated rise in a number of chronic illnesses, including cancer. The market is increased by the use of CT scans to diagnose scans. According to information provided by the Organization for Economic Co-operation and Development, Germany had 19 CT scanners in hospitals and 16 CT scanners in ambulatory care facilities per 1,000,000 residents. Due to the increased prevalence of chronic diseases and the ageing population, more CT scanners are anticipated to be installed nationwide, which will further the market's expansion. New CT scanners will also be introduced in the nation, which will accelerate market expansion. For instance, Baker Hughes company Waygate Technologies introduced the Phoenix Power scan HE, its first high-energy computed tomography (CT) machine, in Germany in December 2020. It can accurately measure internal dimensions of huge parts as well as scan and measure internal features of crucial, high-density components and assemblies. Due to quick cone-beam scanning with unparalleled picture quality, the scanner can produce high-resolution and flawless image quality at up to 75% faster scan speeds. Thus, the introduction of such technological breakthrough will have a huge positive impact on the market.

However, the lack of a clear reimbursement scenario in the country, as well as the high cost of equipment and CT scan procedures, are all projected to hamper market expansion in Germany.

Key Market TrendsOncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period

The major factors attributing to the growth of the cancer applications for the computed tomography segment in Germany include the rise in prevalence of cancer disorders and greater applications of computed tomography devices in diagnosing different types of cancer. There are also many strategic initiatives that are being conducted in Germany, which are expected to boost market growth. According to Globocan 2020, there were 628,519 new cancer cases in Germany in 2020, and 749,559 cases are anticipated by 2040. The country's use of CT scanners, which are used to diagnose many types of cancer, would be influenced by the anticipated increase in cancer cases. As a result, it is anticipated that the market under study will expand significantly during the forecast years. The market is also projected to rise as a result of efforts made by various organizations to enhance cancer screenings in various German regions. The market is also projected to rise as a result of efforts made by various organizations to enhance cancer screenings in various German regions. For instance, the HANSE prevention program with free lung exams for current and former smokers was launched by North German Lung Cancer Centers in April 2021. A mobile study unit traveling between Hannover Medical School (MHH), the University Medical Center Schleswig-Holstein, Lübeck Campus (UKSH), and the LungenClinic Grosshansdorf provided up to 5,000 volunteers with a free assessment in a contemporary low-dose CT scan (near Hamburg). Therefore, it is anticipated that the aforementioned improvements will further enhance market growth in this sector.

Competitive Landscape

Germany computed tomography market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Canon Medical Systems, Koning Corporation, GE Healthcare, Planmeca Group (Planmed OY), and Koninklijke Philips NV among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.